Catégorie : Neurobiologie

Neurocognitive Consequences of Chronic CannabisUse : A Systematic Review and Meta-Analysis, Pedro Rafael Figueiredo et al., 2019

Neurocognitive Consequences of Chronic CannabisUse : A Systematic Review and Meta-Analysis Pedro Rafael Figueiredo, Serenella Tolomeo, J. Douglas Steele, Alexander Baldacchino Neuroscience and Biobehavioral Reviews, 2019 Doi : 10.1016/j.neubiorev.2019.10.014   "Une méta-analyse échoue à mettre en évidence une "toxicité" de l'usage du cannabis à long terme, sur les fonctions neuropsychologiques cognitives"   Highlights  A meta-analysis was conducted to assess the neuropsychological impact of cannabis.  A limited association was found between chronic cannabis use and neurocognitive deficits.  Memory and chronic cannabis smoking were linked. ABSTRACT Cannabis is currently the most used illicit substance in the world with a global widespread distribution. Although its acute neurocognitive effects on human behaviour have [...]

Lire la suite

IACM-Bulletin du 14 Février 2020

IACM-Bulletin du 14 Février 2020 Science/Animal: Le cannabigerol est efficace contre les infections par des bactéries résistantes aux antibiotiques Economy/Écologie: Données sur la quantité d'électricité consommée par l'industrie du cannabis Science/Homme: Environ la moitié des patients souffrant de lombalgie ont pu arrêter toute consommation d'opioïdes après avoir commencé la consommation de cannabis Europe/ONU: La Commission Européenne propose un vote unifié de l'UE sur la programmation de l’OMS sur le cannabis Science/Homme: De nombreux patients atteints d'arthrite consomment du cannabis Science/Homme: Le cannabis peut être utile contre l'insomnie chez les personnes âgées souffrant de douleur [...]

Lire la suite

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines, Federico Zamberlan et al., 2018

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines Federico Zamberlan, Camila Sanz, Rocío Martínez Vivot, Carla Pallavicini, Fire Erowid, Earth Erowid and Enzo Tagliazucchi Frontiers in Integrative Neuroscience, 2018, 12, 54. doi : 10.3389/fnint.2018.00054   Classic psychedelics are substances of paramount cultural and neuroscientific importance. A distinctive feature of psychedelic drugs is the wide range of potential subjective effects they can elicit, known to be deeply influenced by the internal state of the user (“set”) and the surroundings (“setting”). The observation of crosstolerance and a series [...]

Lire la suite

Psychedelics and potential benefits in “healthy normals”: A review of the literature, Sam GANDY, 2019

Psychedelics and potential benefits in “healthy normals”: A review of the literature Sam GANDY Journal of Psychedelic Studies, 2019, 3, (3), 280–287. Doi : 10.1556/2054.2019.029   We are in the midst of a psychedelic research renaissance. With research examining the efficacy of psychedelics as a treatment for a range of mental health indications still in its early stages, there is an increasing body of research to show that careful use of psychedelics can yield a variety of benefits in “healthy normals” and so lead to “the betterment of well people.” Psychedelics have been found to modulate neuroplasticity, and usage in a supportive setting can result [...]

Lire la suite

Longitudinal Changes in Cognition in Young Adult Cannabis Users, Mary Becker et al., 2018

Longitudinal Changes in Cognition in Young Adult Cannabis Users Mary Becker, Paul F. Collins, Ashley Schultz, Snežana Urošević, Brittany Schmaling, and Monica Luciana The Journal of Clinical and Experimental Neuropsychology, 2018, 40, (6), 529–543. doi : 10.1080/13803395.2017.1385729   Abstract Introduction : Adolescent cannabis use (CU) is associated with impaired attention, executive function, and verbal learning/memory. These associations are generally observed in cross-sectional studies. Longitudinal studies of cannabis users are lacking. Method : The present study examines associations between CU and cognition over time in chronic daily adolescent-onset CUs, as compared to non-using controls. Both groups completed a neuropsychological battery at study intake and again two years later. Results [...]

Lire la suite

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial, Steliana Yanakieva et al., 2018

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial Steliana Yanakieva, Naya Polychroni, Neiloufar Family, Luke T. J. Williams, David P. Luke, Devin B. Terhune Psychopharmacology, 2018 Doi : 10.1007/s00213-018-5119-x   Abstract Rationale : Previous research demonstrating that lysergic acid diethylamide (LSD) produces alterations in time perception has implications for its impact on conscious states and a range of psychological functions that necessitate precise interval timing. However, interpretation of this research is hindered by methodological limitations and an inability to dissociate direct neurochemical effects on interval timing from indirect effects attributable to altered states of consciousness. Methods : We conducted a randomised, double-blind, [...]

Lire la suite

THCp – Newly discovered and highly potent phytocannabinoid, cannabislifenetwork.com, 2020

THCp – Newly discovered and highly potent phytocannabinoid Source : cannabislifenetwork.com Publié le 1 Fév 2020 We have discovered so much about cannabis over the years, but it’s vast, intricate, pharmacological map is missing many major regions. CBD dominant varieties have exploded in demand, yet the cannabinoid is still only partially understood, and there is still CBG and CBN just around the market’s corner. Now, brand new forms of THC and CBD, THCp and CBDp, respectively, have been discovered; evidence that the map’s expanse is still beyond our grasp. Phytocannabinoids over synthetics Lately, stories of newly discovered cannabinoids are strewn with the accomplishments of a biochemist [...]

Lire la suite

Les troubles cognitifs et psychiatriques liés à la consommation de cannabis, Alain DERVAUX, 2014

Les troubles cognitifs et psychiatriques liés à la consommation de cannabis Alain DERVAUX, Marie-Odile KREBS , Xavier LAQUEILLE Bulletin de l'Académie Nationale de Médecine, 2014, 198, no 3, 559-577, séance du 25 mars 2014   RÉSUMÉ Plusieurs études ont montré que le Δ-9-THC, principal principe actif du cannabis entraînait des troubles de l’attention, de la mémoire et des fonctions exécutives. Ils sont liés à la dose, à la fréquence, à la durée d’exposition et à l’âge de la première consommation. Ils peuvent disparaître après sevrage, mais des anomalies durables s’observent chez les sujets ayant débuté leur consommation avant l’âge de 15 ans. La fréquence de [...]

Lire la suite

Psychological Explorations of the Magic Mushroom (Psilocybin) Experience, Part II : Neuropsychological Measures José Arturo Costa Escobar & Antonio Roazzi, 2011

Psychological Explorations of the Magic Mushroom (Psilocybin) Experience, Part II : Neuropsychological Measures José Arturo Costa Escobar, M.S., Antonio Roazzi, Ph.D. Neurobiologia, 2011, 74, (3-4), 99-112.   ABSTRACT Some investigations conducted with psilocybin and mushrooms of the Psilocybe genus on the human mind point to a peculiarity of these substances to promote a special state of consciousness. The present study measured the effects of dehydrated magic mushrooms on human visual processes and memory utilizing tasks in a pre- and post-test form. We observed defi cits in visual working memory and these results were consistent with other, recent psilocybin studies. However this and other visual mechanisms [...]

Lire la suite

A tale of two cannabinoids : The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol, Ethan Russo & Geoffrey W. Guy, 2006

A tale of two cannabinoids : The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol Ethan Russo & Geoffrey W. Guy Medical Hypotheses, 2006, 66, 234–246 doi : 10.1016/j.mehy.2005.08.026 Summary This study examines the current knowledge of physiological and clinical effects of tetrahydrocannabinol (THC) and cannabidiol (CBD) and presents a rationale for their combination in pharmaceutical preparations. Cannabinoid and vanilloid receptor effects as well as non-receptor mechanisms are explored, such as the capability of THC and CBD to act as anti-inflammatory substances independent of cyclo-oxygenase (COX) inhibition. CBD is demonstrated to antagonise some undesirable effects of THC including intoxication, sedation and tachycardia, while contributing analgesic, anti-emetic, [...]

Lire la suite